Vancouver, British Columbia--(Newsfile Corp. - February 6, 2024) - Genix Pharmaceuticals Corporation (TSXV: GENX) (OTCQB: GENPF) ("GENIX" or the "Company") announces that pursuant to its news release ...
Vancouver, British Columbia--(Newsfile Corp. - January 18, 2024) - Genix Pharmaceuticals Corporation (TSXV: GENX) (OTCQB: GENPF) ("GENIX" or the "Company") announces that the Company has made an ...
Vancouver, British Columbia--(Newsfile Corp. - March 22, 2021) - Genix Pharmaceuticals Corporation (TSXV: GENX) ("GENIX" or the "Company") GENIX is pleased to announce that it has entered into an ...
Vancouver, British Columbia--(Newsfile Corp. - September 22, 2020) - Genix Pharmaceuticals Corporation (TSXV: GENX) ("GENIX" or the "Company") announces the results of its annual general meeting of ...
Vancouver, British Columbia,--(Newsfile Corp. - April 1, 2021) - Genix Pharmaceuticals Corporation (TSXV: GENX) ("GENIX" or the "Company") is pleased to announce that it has entered into an exclusive ...
* The total warrants have been corrected from the following press releases announced on June 22, 2020, July 17, 2020, August 6, 2022, July 20, 2022, July 28 2022. The Company notes that previous press ...